September 26, 2024
Guinea pigs are important to Ohio State University leukemia specialist Kerry A. Rogers, MD, but not because they’re in her research laboratory, where the focus is […]
September 26, 2024
TOPLINE: Patients with stage I non–small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) have a low rate of acute toxicities and 90-day mortality, […]
September 26, 2024
The monthly cost of treating disease is not associated with a patient with breast cancer surviving or the disease worsening, according to new research. A key […]
September 26, 2024
BARCELONA, Spain — A trial conducted across 40 Italian centers has underscored the significance of a new mutational approach to cancer research. The Rome Study, presented […]
September 26, 2024
Providing genetic testing for BRCA1 and BRCA2 mutations in all women aged 30 years or older would be cost-effective and prevent more breast and ovarian cancers […]
September 25, 2024
Employing MRI-targeted biopsy instead of systematic biopsy reduces overdiagnosis of low-grade prostate cancer by more than half, although diagnoses may be delayed among a small minority […]
September 25, 2024
TOPLINE: Electronic health record (EHR)–derived family history identified 29,913 patients with familial risk for hereditary breast and ovarian cancer, but 82% had no evidence of genetic […]
September 25, 2024
TOPLINE: Survival rates for patients with hepatocellular carcinoma (HCC) have improved, but overall survival remains low. Early detection and treatment significantly enhanced survival outcomes between January […]
September 25, 2024
(Reuters) -Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously treated patients with […]